We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.5B
AUM Growth
+$219M
Cap. Flow
+$156M
Cap. Flow %
10.37%
Top 10 Hldgs %
19.84%
Holding
2,472
New
220
Increased
918
Reduced
391
Closed
67

Top Buys

Rank Stock Value
1
FCTR icon
First Trust Lunt US Factor Rotation ETF
FCTR
+$21.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$13.3M
3
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$8.95M
4
DALT
Anfield Diversified Alternatives ETF
DALT
+$6.31M
5
VHT icon
Vanguard Health Care ETF
VHT
+$6.16M

Top Sells

Rank Stock Value
1
LVHB
Innovator Lunt Low Vol/High Beta Tactical ETF
LVHB
+$26.2M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$8.08M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$5.49M
4
CSCO icon
Cisco
CSCO
+$5.24M
5
WFC icon
Wells Fargo
WFC
+$5.12M

Sector Composition

Rank Sector Weight
1 Technology 6.53%
2 Energy 6.29%
3 Industrials 6.24%
4 Healthcare 5.52%
5 Financials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIW
2376
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$505M
$1K ﹤0.01%
162
– –
WKHS icon
2377
Workhorse Group
WKHS
$33.2M
– –
0
– –
EVBN
2378
DELISTED
Evans Bancorp Inc
EVBN
$1K ﹤0.01%
+41
New +$1.93K
ITI
2379
DELISTED
Iteris, Inc.
ITI
$1K ﹤0.01%
300
– –
EGRX
2380
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
25
– –
CBAY
2381
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
+100
New +$1.24K
IMGN
2382
DELISTED
Immunogen Inc
IMGN
$1K ﹤0.01%
164
– –
PACW
2383
DELISTED
PacWest Bancorp
PACW
$1K ﹤0.01%
28
– –
AEY
2384
DELISTED
ADDvantage Technologies Group
AEY
$1K ﹤0.01%
119
– –
WTT
2385
DELISTED
Wireless Telecom Group, Inc.
WTT
$1K ﹤0.01%
1,000
– –
UNAM
2386
DELISTED
Unico American Corp
UNAM
$1K ﹤0.01%
220
– –
DBD
2387
DELISTED
Diebold Nixdorf Incorporated
DBD
$1K ﹤0.01%
413
– –
ELOX
2388
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$1K ﹤0.01%
2
– –
RADA
2389
DELISTED
Rada Electronic Industries Ltd
RADA
$1K ﹤0.01%
500
– –
GCP
2390
DELISTED
GCP Applied Technologies Inc.
GCP
$1K ﹤0.01%
40
– –
MTOR
2391
DELISTED
MERITOR, Inc.
MTOR
$1K ﹤0.01%
69
– –
KL
2392
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1K ﹤0.01%
100
– –
ARD
2393
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$1K ﹤0.01%
63
– –
ALSK
2394
DELISTED
Alaska Communications Systems
ALSK
$1K ﹤0.01%
1,000
– –
PRAH
2395
DELISTED
PRA Health Sciences, Inc.
PRAH
$1K ﹤0.01%
13
– –
GSP
2396
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$1K ﹤0.01%
100
– –
SYV
2397
DELISTED
SPDR MFS Systematic Value Equity ETF of SSgA Active Trust
SYV
$1K ﹤0.01%
25
– –
SVA
2398
DELISTED
Sinovac Biotech, Ltd
SVA
$1K ﹤0.01%
150
– –
DOC
2399
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1K ﹤0.01%
+61
New +$1.01K
AGQ icon
2400
ProShares Ultra Silver
AGQ
$1.13B
– –
-150
Closed -$4K
94 95
96
97 98

Similar funds

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.33B AUM 18.98% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Geneos Wealth Management's Q3 2018 Portfolio in Review

As of Q3 2018, Geneos Wealth Management held 2,472 positions worth $1.5B, up 17% from $1.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management deployed $156M of net new capital in Q3 2018, opening 220 new positions and adding to 918 existing holdings. Its largest new stake was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 6.3% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, an estimated $26.2M trimmed.

  • Geneos Wealth Management's largest Q3 2018 buy was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $13.3M increase.
  • Geneos Wealth Management's biggest Q3 2018 reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, cutting an estimated $26.2M.
  • Geneos Wealth Management fully exited iShares Currency Hedged MSCI Eurozone ETF in Q3 2018, selling an estimated $2.34M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $1.5B portfolio in Q3 2018.
  • Geneos Wealth Management opened 220 new positions and closed 67 in Q3 2018.
  • Geneos Wealth Management's portfolio value rose 17% quarter-over-quarter to $1.5B.

Based on Geneos Wealth Management's 13F filing for Q3 2018, filed 7 Sep 2021.